The ‘Edison Accelerator’ provides world-class clinical, technical and commercial mentorship to EMEA-based start-ups London, UK – 24 June 2021 – Six healthtech start-ups have officially become the first cohort of the Edison Accelerator in EMEA – a healthcare start-up and scale-up acceleration programme designed by GE Healthcare in partnership with innovation organisation Wayra UK. The... Read more
ANDOVER, Mass., June 15, 2021 (GLOBE NEWSWIRE) — MKS Instruments, Inc . (NASDAQ: MKSI “MKS”), a global provider of technologies that enable advanced processes and improve productivity, today announced that it is celebrating the 60 th anniversary of the founding of the company. John T.C. Read more
Data for EVRYSDI reinforce safety profile and efficacy in a broad spinal muscular atrophy (SMA) population, following recent EU approval Data for ENSPRYNG in neuromyelitis optica spectrum disorder (NMOSD) build on safety profile and efficacy following recent CHMP opinion, including in adults with concomitant autoimmune diseases (CAIDs) OCREVUS data continue to show consistent benefit on... Read more
The SARS-CoV-2 Antigen Self Test Nasal enables individuals to quickly and conveniently test themselves for COVID-19 at home using a simple nasal swab An early version of the test has already been available as a home-test in a number of European markets under local special approval pathways since February 2021 The test will be widely... Read more
On June 2, 2021, JEOL will focus on advances in life science research using electron microscopy in its “24 Hours of Life Science” conference. Twenty-four different sessions throughout the full day will cover topics including: – Connectomics and the study of complete volumes of tissues or materials captured at high resolution– Correlative microscopy using light... Read more
ANDOVER, Mass., May 12, 2021 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.22 per share, a ten percent Read more
GE Healthcare to scale Zionexa’s FDA-approved PET imaging agent, Cerianna (fluoroestradiol F-18), used as an adjunct to biopsy for the detection of estrogen receptor (ER) positive lesions to help inform treatment selection for patients with recurrent or metastatic breast cancer Aims to make Cerianna available to 75% of metastatic breast cancer patients in the U.S.... Read more
Tecentriq significantly improved overall survival in people with high PD-L1 expression, compared with chemotherapy in a Phase III study Tecentriq approval offers an alternative to chemotherapy for all eligible patients This approval marks Tecentriq’s fourth indication in metastatic non-small cell lung cancer and fifth indication in lung cancer overall in the EU Basel, 5 May... Read more
MENLO PARK, Calif., May 04, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conferences: BofA Securities 2021 Virtual Health Care Conference on Thursday, May 13, 2021 at 2:00 p.m. EDT UBS Global Healthcare Virtual Conference on Tuesday, May 25, 2021... Read more
MENLO PARK, Calif., April 27, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, announced today that Dr. Hannah Valantine has been nominated for election to the Company’s Board of Directors as a Class II director at the Company’s 2021 Annual Meeting of Stockholders. Dr.... Read more